This article discusses the retiring of Ph. Eur. and USP heavy metal assays as well as a means of updating related specifications with minimal regulatory burden.
Lina Wong
Advertisement
Lina Wong is associate director, Global Quality Assurance, Allergan.
Articles by Lina Wong
The authors support the retiring of Ph. Eur. and USP heavy metal assays and propose a means of updating related specifications with minimal regulatory burden.
Advertisement
Latest Updated Articles
Pharma Collaboration Proposes Retirement of Obsolete Heavy Metals TestsPublished: September 1st 2018 | Updated:
- Retirement for Obsolete Heavy Metals Tests
Published: October 3rd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
3
Why Context Matters in Validating Biomarker Assays for Bioanalysis
4
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
5
